Nuclear but not cytosolic phosphoinositide 3-kinase beta has an essential function in cell survival

Molecular and Cellular Biology

Volumn 31, Issue 10, 2011, Pages 2122-2133

  Kumar, Amit ^a   Redondo Muñoz, Javier ^a   Perez García, Vicente ^a   Cortes, Isabel ^a   Chagoyen, Monica ^a   Carrera, Ana C ^a  

^a CENTRO NACIONAL DE BIOTECNOLOGÍA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

MUTANT PROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3 KINASE BETA; PROTEIN P110; PROTEIN P85; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; BETA CHAIN; CELL SURVIVAL; CONTROLLED STUDY; CYTOPLASM; EMBRYO; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; NUCLEAR EXPORT SIGNAL; NUCLEAR LOCALIZATION SIGNAL; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FUNCTION;

AMINO ACID SEQUENCE; ANIMALS; APOPTOSIS; BLOTTING, WESTERN; CELL LINE; CELL NUCLEUS; CELL SURVIVAL; CLASS IA PHOSPHATIDYLINOSITOL 3-KINASE; CYTOSOL; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; IMMUNOPRECIPITATION; MICE; MOLECULAR SEQUENCE DATA; NIH 3T3 CELLS; NUCLEAR EXPORT SIGNALS; NUCLEAR LOCALIZATION SIGNALS; PHOSPHATIDYLINOSITOL 3-KINASES; SIGNAL TRANSDUCTION;

EID: 79956108913     PISSN: 02707306     EISSN: 10985549     Source Type: Journal    
DOI: 10.1128/MCB.01313-10     Document Type: Article

References (60)

1. Ahn, J. Y., R. Rong, X. Liu, and K. Ye. 2004. PIKE/nuclear PI3K signaling mediates the antiapoptotic actions of NGF in the nucleus. EMBO J. 23:3995-4006.
2. Alcázar, I., et al. 2009. p85β PI3K regulates CD28 coreceptor function. Blood 113:3198-3208.
3. Arnold, K. L. Bordoli, J. Kopp, and T. Schwede. 2006. The Swiss-MODEL Workspace: a web-based environment for protein structure homology modeling. Bioinformatics 22:195-201.
4. Berndt, A., et al. 2010. The p110δ structure: mechanisms for selectivity and potency of new PI(3)K inhibitors. Nat. Chem. Biol. 6:117-124.
5. Bi, L., I. Okabe, D. J. Bernard, and R. L. Nussbaum. 2002. Early embryonic lethality in mice deficient in the p110β catalytic subunit of PI3K. Mamm. Genome 13:169-172.
6. Bi, L., I. Okabe, D. J. Bernard, A. Wynshaw-Boris, and R. L. Nussbaum. 1999. Proliferative defect and embryonic lethality in mice homozygous for a deletion in the p110α subunit of PI3K. J. Biol. Chem. 274:10963-10968.
7. Carvalho, S., F. Milanezi, J. L. Costa, I. Amendoeira, and F. Schmitt. 2010. PIKing the right isoform: the emergent role of the p110β subunit in breast cancer. Virchows Arch. 456:235-243.
8. Czauderna, F., et al. 2003. Functional studies of the PI(3)-kinase signaling pathway employing synthetic and expressed shRNA. Nucleic Acids Res. 31:670-682.
9. Denley, A., S. Kang, U. Karst, and P. K. Vogt. 2008. Oncogenic signaling of class I PI3K isoforms. Oncogene 27:2561-2574.
10. Didichenko, S. A., and M. Thelen. 2001. PI3K c2α contains a nuclear localization sequence and associates with nuclear speckles. J. Biol. Chem. 276:48135-48142.
11. Fornerod, M., M. Ohno, M. Yoshida, and I. W. Mattaj. 1997. CRM1 is an export receptor for leucine-rich nuclear export signals. Cell 90:1051-1060.
12. Foukas, L. C., I. M. Berenjeno, A. Gray, A. Khwaja, and B. Vanhaesebroeck. 2010. Activity of any class IA PI3K isoform can sustain cell proliferation and survival. Proc. Natl. Acad. Sci. U. S. A. 107:11381-11386.
13. Foukas, L. C., et al. 2006. Critical role for the p110α PI3K in growth and metabolic regulation. Nature 441:366-370.
14. Fruman, D. A., R. E. Meyers, and L. C. Cantley. 1998. Phosphoinositide kinases. Annu. Rev. Biochem. 67:481-507.
15. García, Z., et al. 2006. A PI3K activity-independent function of p85 subunit in control of mammalian cytokinesis. EMBO J. 25:4740-4751.
16. Geering, B., P. R. Cutillas, G. Nock, S. I. Gharbi, and B. Vanhaesebroeck. 2007. Class IA PI3K are obligate p85-p110 heterodimers. Proc. Natl. Acad. Sci. U. S. A. 104:7809-7814.
17. Gil, A., et al. 2006. Nuclear localization of PTEN by a Ran-dependent mechanism enhances apoptosis: involvement of an N-terminal nuclear localization domain and multiple nuclear exclusion motifs. Mol. Biol. Cell 17:4002-4013.
18. Hiles, I. D., et al. 1992. PI3K: structure and expression of the 110-kDa catalytic subunit. Cell 70:419-429.
19. Holm, L., and P. Rosenström. 2010. Dali server: conservation mapping in 3D. Nucleic Acids Res. 38:W545-W549.
20. Hsu, C. Y., and B. Y. Yung. 2000. Over-expression of nucleophosmin/B23 decreases the susceptibility of human leukemia HL-60 cells to retinoic acidinduced differentiation and apoptosis. Int. J. Cancer 88:392-400.
21. Hu, P., A. Mondino, E. Y. Skolnik, and J. Schlessinger. 1993. Cloning of a novel, ubiquitously expressed human PI3K and identification of its binding site on p85. Mol. Cell. Biol. 13:7677-7688.
22. Hu, Q., A. Klippel, A. J. Muslin, W. J. Fantl, and L. T. Williams. 1995. Ras-dependent induction of cellular responses by constitutively active phosphatidylinositol-3 kinase. Science 268:100-102.
23. Hu, Y., et al. 2005. Akt phosphorylates acinus and inhibits its proteolytic cleavage, preventing chromatin condensation. EMBO J. 24:3543-3554.
24. Huang, C. H., et al. 2007. The structure of a human p110α/p85α complex elucidates the effects of oncogenic PI3Kα mutations. Science 318:1744-1748.
25. Janssen, J. W. G., L. Schelithoff, C. R. Bartram, and A. S. Schulz. 1998. An oncogenic fusion product of the PI3K p85β subunit and HUMORF8, a putative deubiquitinating enzyme. Oncogene 16:1767-1772.
26. Jia, S., et al. 2008. Essential roles of PI(3)K-p110β in cell growth, metabolism, and tumorigenesis. Nature 454:776-779.
27. Jiménez, C., et al. 1998. Identification and characterization of a new oncogene derived from the regulatory subunit of PI3K. EMBO J. 17:743-753.
28. Kaffman, A., and E. K. O'Shea. 1999. Regulation of nuclear localization: a key to a door. Annu. Rev. Cell Dev. Biol. 15:291-339.
29. Kang, S., A. G. Bader, and P. K. Vogt. 2005. PI3K mutations identified in human cancer are oncogenic. Proc. Natl. Acad. Sci. U. S. A. 102:802-807.
30. Kau, T. R., and P. A. Silver. 2003. Nuclear transport as a target for cell growth. Drug Discov. Today 8:78-85.
31. Kudo, N., et al. 1998. Leptomycin B inhibition of signal-mediated nuclear export by direct binding to CRM1. Exp. Cell Res. 242:540-547.
32. Kumar, A., O. Fernández-Capetillo, and A. C. Carrera. 2010. Nuclear PI3Kβ controls double-strand break DNA repair. Proc. Natl. Acad. Sci. U. S. A. 107:7491-7496.
33. Mandelker, D., et al. 2009. A frequent kinase domain mutation that changes the interaction between PI3Kα and the membrane. Proc. Natl. Acad. Sci. U. S. A. 106:16996-17001.
34. 1 phase. Mol. Cell. Biol. 28:2803-2814.
35. Marqués, M., et al. 2009. Specific function of PI3K beta in the control of DNA replication. Proc. Natl. Acad. Sci. U. S. A. 106:7525-7530.
36. Martelli, A. M., et al. 2007. Nuclear phosphatidylinositol 3,4,5-trisphosphate, phosphatidylinositol 3-kinase, Akt, and PTEN: emerging key regulators of antiapoptotic signaling and carcinogenesis. Eur. J. Histochem. 51(Suppl. 1):125-131.
37. Martelli, A. M., et al. 2006. Intranuclear 3′-phosphoinositide metabolism and Akt signaling: new mechanisms for tumorigenesis and protection against apoptosis? Cell Signal. 18:1101-1107.
38. Martelli, A. M., et al. 2006. PI3K /Akt signaling pathway and its therapeutic implications for human acute myeloid leukemia. Leukemia 20:911-928.
39. Martínez-Gac, L., M. Marqués, Z. García, M. R. Campanero, and A. C. Carrera. 2004. Control of cyclin G2 mRNA expression by forkhead transcription factors: novel mechanism for cell cycle control by PI3K and forkhead. Mol. Cell. Biol. 24:2181-2189.
40. Méndez, J., and B. Stillman. 2000. Chromatin association of human origin recognition complex, cdc6, and minichromosome maintenance proteins during the cell cycle: assembly of prereplication complexes in late mitosis. Mol. Cell. Biol. 20:8602-8612.
41. Metjian, A., R. L. Roll, A. D. Ma, and C. S. Abrams. 1999. Agonists cause nuclear translocation of PI3Kγ: a Gβγ-dependent pathway that requires the p110γ amino terminus. J. Biol. Chem. 274:27943-27947.
42. Miled, N., et al. 2007. Mechanism of two classes of cancer mutations in the PI3K catalytic subunit. Science 317:239-2342.
43. Neri, L. M., P. Borgatti, S. Capitani, and A. M. Martelli. 2002. The nuclear PI3K/AKT pathway: a new second messenger system. Biochim. Biophys. Acta 1584:73-80.
44. Okkenhaug, K., et al. 2002. Impaired B and T cell antigen receptor signaling in p110δ PI3K mutant mice. Science 297:1031-1104.
45. Pacold, M. E., et al. 2000. Crystal structure and functional analysis of Ras binding to its effector PI3Kγ. Cell 103:931-943.
46. Park, S. W., et al. 2020. The regulatory subunits of PI3K, p85α and p85β, interact with XBP-1 and increase its nuclear translocation. Nat. Med. 16:429-437.
47. Roche, S., J. Downward, P. Raynal, and S. A. Courtneidge. 1998. A function for PI3Kβ (p85α-p110β) in fibroblasts during mitogenesis: requirement for insulin- and lysophosphatidic acid-mediated signal transduction. Mol. Cell. Biol. 18:7119-7129.
48. Sengupta, T. K., S. Bandyopadhyay, D. J. Fernandes, and E. K. Spicer. 2004. Identification of nucleolin as an AU-rich element binding protein involved in bcl-2 mRNA stabilization. J. Biol. Chem. 279:10855-10863.
49. Ström, A. C., and K. Weis. 2001. Importin-beta-like nuclear transport receptors. Genome Biol. 2:3008.1-3008.9.
50. Suire, S., et al. 2005. p84, a new Gβγ-activated regulatory subunit of the type IB phosphoinositide 3-kinase p110γ. Curr. Biol. 15:566-570.
51. Tanaka, K., et al. 1999. Evidence that a phosphatidylinositol 3,4,5-trisphosphate-binding protein can function in nucleus. J. Biol. Chem. 274:3919-3922.
52. van der Spoel, D., et al. 2005. GROMACS: fast, flexible, and free. J. Comput. Chem. 26:1701-1718.
53. Vanhaesebroeck, B., S. J. Leevers, G. Panayotou, and M. D. Waterfield. 1997. PI3K: a conserved family of signal transducers. Trends Biochem. Sci. 22:267-272.
54. Wee, S., et al. 2008. PTEN-deficient cancers depend on PIK3CB. Proc. Natl. Acad. Sci. U. S. A. 105:13057-13062.
55. Wu, M. H., J. H. Chang, and B. Y. Yung. 2002. Resistance to UV-induced cell-killing in nucleophosmin/B23 overexpressed NIH 3T3 fibroblasts: enhancement of DNA repair and up-regulation of PCNA in association with nucleophosmin/B23 overexpression. Carcinogenesis 23:93-100.
56. Ye, K., et al. 2002. Phospholipase Cγ1 is a physiological guanine nucleotide exchange factor for the nuclear GTPase PIKE. Nature 415:541-544.
57. Ye, K., et al. 2000. Pike. A nuclear GTPase that enhances PI3 kinase activity and is regulated by protein 4.1N. Cell 103:919-930.
58. Yip, S. C., et al. 2004. Over-expression of the p110beta but not p110α isoform of PI3K inhibits motility in breast cancer cells. Cell Motil. Cytoskeleton 59:180-188.
59. Yoshida, H., M. Oku, M. Suzuki, and K. Mori. 2006. pXBP1(U) encoded in XBP1 pre-mRNA negatively regulates unfolded protein response activator pXBP1(S) in mammalian ER stress response. J. Cell Biol. 172:565-575.
60. Zhang Y. 2008. I-TASSER server for protein 3D structure prediction. BMC Bioinformatics 9:40.